Produkty 298-36-2

CAS 298-36-2 występuje w naszej ofercie pod nazwami: 5alpha-Dihydrodeoxycorticosterone, 5α-Dihydrodeoxycorticosterone, ≥95%, ≥95%, 5α-Dihydrodeoxycorticosterone, 98.0%. Oferty producentów: TRC, Chemat, MedChemExpress. Dostępne opakowania: 100mg, 5mg, 25mg, 50mg, 10 mg, 5 mg.

5alpha-Dihydrodeoxycorticosterone
TRC
  • opakowanie: 100mg
  • Warianty: 1
Zobacz produkt
5α-Dihydrodeoxycorticosterone, ≥95%, ≥95%
Chemat
  • opakowanie: 5mg, 25mg, 50mg
  • Warianty: 3
od 458,00
Zobacz produkt
5α-Dihydrodeoxycorticosterone, 98.0%
MedChemExpress
  • opakowanie: 10 mg, 5 mg
  • Warianty: 2
od 686,57
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(5S,8R,9S,10S,13S,14S,17S)-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one (CAS 298-36-2) to związek chemiczny o wzorze sumarycznym C21H32O3 i masie molowej 332.5 g/mol. Nazwa systematyczna IUPAC: (5S,8R,9S,10S,13S,14S,17S)-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one. InChIKey: USPYDUPOCUYHQL-KVHKMPIWSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H32O3
Masa molowa332.5 g/mol
Nazwa IUPAC(5S,8R,9S,10S,13S,14S,17S)-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one
InChIKeyUSPYDUPOCUYHQL-KVHKMPIWSA-N
SMILESC[C@]12CCC(=O)C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4C(=O)CO)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 5alpha-Dihydrodeoxycorticosterone, 5alpha-Pregnan-21-ol-3,20-dione, Pregnane-3,20-dione, 21-hydroxy-, (5alpha)-, 5alpha-Pregnane-3,20-dione, 21-hydroxy-, 5.alpha.-Pregnan-21-ol-3,20-dione, (5alpha)-21-hydroxypregnane-3,20-dione, 21-Hydroxy-5alpha-pregnane-3,20-dione, Allopregnane-21-ol-3,20-dione, 5|A-Dihydrodeoxycorticosterone, dihydrodeoxycorticosterone
Powiązane formy tego związku
(5R,8R,9S,10S,13S,14S,17S)-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one C21H32O3
Izomery (ten sam wzór sumaryczny)
methyl (1R,4S,5R,9S,10R,13S)-13-hydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylate C21H32O3
(4-propoxyphenyl) 4-pentylcyclohexane-1-carboxylate C21H32O3
(4-pentoxyphenyl) 4-propylcyclohexane-1-carboxylate C21H32O3
methyl 4-[(2S,3S)-3-[(1E,3E,5Z,8Z)-tetradeca-1,3,5,8-tetraenyl]oxiran-2-yl]butanoate C21H32O3
methyl 4-[3-[(2Z,5Z,8Z,11Z)-tetradeca-2,5,8,11-tetraenyl]oxiran-2-yl]butanoate C21H32O3
(8R,9S,10R,13S,14S,17R)-17-hydroxy-17-[(1S)-1-hydroxyethyl]-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H32O3
(1R,2R,3aS,9aS)-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalene-2,5-diol C21H32O3
(3R,5S,8S,9S,10S,13S,14S,17S)-17-acetyl-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one C21H32O3
[(3S,8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate C21H32O3
(7R,8R,9S,13S,14S)-3,3-dimethoxy-7,13-dimethyl-1,2,4,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C21H32O3
1-[(3S,8R,9S,10R,13S,14S,17R)-3,17-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethanone C21H32O3